March 10, 2014 — The need to assess breast density as part of routine mammography is well documented and is required by legislation in many states. Vucomp’s U.S. Food and Drug Administration (FDA)-cleared M-Vu Breast Density automatically assesses breast density, providing consistent and accurate measurements calibrated to a panel of 13 expert radiologists.

M-Vu Breast Density evaluates mammograms in much the same manner as experienced radiologists do: by analyzing the structure and texture of the tissue, rather than simply estimating total fibroglandular volume. This exclusive approach using appearance-based analysis provides useful adjunctive information. The resulting M-Vu Breast Density category is analogous to the BI-RADS density category, which reflects the degree to which the mammographic image exhibits a breast pattern that could camouflage cancer.

For physicians, this means fast and consistent assessments. For patients, it means peace of mind.

"We find M-Vu Breast Density very beneficial in providing consistent accurate breast density reads across our practice,” said Christine A. J. Granfield, M.D. Medical Director for Breast Imaging, Baptist Health. “While we already were providing the breast density estimate in the dictated report, it is reassuring to know we are now reporting this information accurately to the primary physician, which in turn can effect their patient management."

M-Vu Breast Density is compatible with mammography systems of Carestream, Fujifilm, GE, Giotto, Hologic, Konica Minolta, Philips, Planmed and Siemens. The tower or rack server communicates over Ethernet network. The product can be combined with the M-Vu CAD system for a comprehensive set of tools to help radiologists find breast cancer earlier, and Vucomp resources are ready and available to ensure an efficient installation.

For more information: www.vucomp.com


Related Content

News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
Subscribe Now